Lower GI(Reg3α,TIM3) (22) and liver (HGF, KRT18) (31) IL-6 has been implicated as a pro inflammatory agent in the context of GvHD and blocking this appears to have a dampening effect on GvHD (32). Here, HAVCR2 is linked to graft versus host disease.